These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C. J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586 [Abstract] [Full Text] [Related]
15. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience. Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O. Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652 [Abstract] [Full Text] [Related]
16. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry. Zimmermann H, Oschlies I, Fink S, Pott C, Neumayer HH, Lehmkuhl H, Hauser IA, Dreyling M, Kneba M, Gärtner B, Anagnostopoulos I, Riess H, Klapper W, Trappe RU. Transplantation; 2012 Mar 15; 93(5):543-50. PubMed ID: 22234349 [Abstract] [Full Text] [Related]
17. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT. Transplant Proc; 2010 Jun 15; 42(5):1763-8. PubMed ID: 20620519 [Abstract] [Full Text] [Related]